Aldehydes and disturbance of carbohydrate metabolism: Some consequences and possible approaches to its normalization

Archives of Physiology and Biochemistry

Volumn 113, Issue 2, 2007, Pages 87-95

  Dmitriev, L F ^a   Dugin, S F ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

Carbohydrate metabolism; Hyperglycemia; Methylglyoxal; Tocopherol

Indexed keywords

ALDEHYDE; INSULIN;

ANIMAL; ARTICLE; CARBOHYDRATE METABOLISM; HUMAN; HYPERGLYCEMIA; METABOLISM; PHYSIOLOGY;

ALDEHYDES; ANIMALS; CARBOHYDRATE METABOLISM; HUMANS; HYPERGLYCEMIA; INSULIN;

EID: 34250194306     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450701384783     Document Type: Article

References (80)

1. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hardo E, Minnenmann T, Shulman GI, Kahn B. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409:729-33.
2. 2+-ascorbate induced lipid peroxidation and effect of phosphoglucose isomerase. Mol Cell Biochem 289:49-53.
3. Akhand A, Hossain K, Mitsui H, Kato M, Miyata T, Inagi R, Du J, Takeda K, Kawamoto Y, Suzuki H, et al. 2001. Glyoxal and methylglyoxal induce lyoxal and methyglyoxal induce aggregation and inactivation of ERK in human endothelial cells. Free Radic Biol Med 31:20-30.
4. Aleksandrovski Y. 2002. Molecular mechanisms of the cross-impact of pathological processes in combined diabetes and cancer. Research and clinical aspects. Biochemistry (Mosc) 67:1329-46.
5. Azzi A. 2004. The role of alpha-tocopherol in preventing disease. Bur J Nutr 43(suppl. 1):118-25.
6. Baron A, Brechtel G. 1993. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol Endocrinol Metabol 265:E61-7.
7. Beisswenger P, Howell S, Smith K, Szwergold B. 2003. Gliyceraldehyde-3- phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 1637:98-104.
8. Beisswenger P, Howell S, Touchette A, Lal S, Szwergold B. 1999. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 48:198-202.
9. Berstein L, Vasilyev D, Poroshina T, Kovalenko I. 2006. Glucose-induced effects and joker function of glucose: Endocrine and genotoxic prevalence? Horm Metab Res 38:650-5.
10. Biswas S, Gairola C, Das S. 2002. Passive cigarette smoke and the renal glyoxalase system. Mol Cell Biochem 229:153-6.
11. Bouche C, Serdy S, Kahn C, Goldfine A. 2004. The cellular fate of glucose and its relevance in 2 type diabetes. Endocr Rev 25:807-30.
12. Chang K, Paek K, Kim H, Lee Y, Yabe-Nishimura C, Seo H. 2002. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol Pharmacol 61:1184-91.
13. Chellan P, Nagaraj R. 1999. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes. Arch Biochem Biophys 368:98104.
14. Chin C, Lipton P, Roberts E Jr. 2001. Do active cerebral neurons really use lactate rather than glucose? Trends Neurosci 24:573-8.
15. Cohen A, Comb T, Scherer P, Lisanti M. 2003. Role of caveolin and caveolae in insulin signaling and diabetes. Am J Physiol Endocrinol Metabol 285:E1151-60.
16. Cook S, Scherrer U. 2002. Insulin resistance, a new target for nitric oxide-delivery drugs. Fundam Clin Pharmacol 16:441-53.
17. Dandona P, Thusu K, Cook S, Snyder B, Makowsky J, Armstrong D, Nicotera T. 1996. Oxidative damage to DNA in diabetes mellitus. Lancet 344:444-5.
18. Dmitriev L. 1998. Cytochrome b5 and tocopherol provide functions of lipid-radical cycles and energy conversion in membranes. Biochemistry (Mosc) 63:1233-6.
19. Dukic-Stefanovic S, Schinzel R, Riederer P, Munch G. 2001. AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs? Biogerontology 2:19-34.
20. Duval H, Harris M, Li J, Johnson N, Print C. 2003. New insights into the function and regulation of endothelial cell apoptosis. Angiogenesis 6:171-83.
21. Ellis J, Folkers K, Minadeo M, VanBuskirk R, Xia L, Tamagawa H. 1991. A deficiency of vitamin B6 is a plausible molecular basis of the retinopathy of patients with diabetes mellitus. Biochem Biophys Res Commun 179:615-9.
22. Esterbauer H, Schaur R, Zollner H. 1991. Chemistry and biochemistry of 4-hydroxy-nonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128.
23. Evans J, Goldfine I, Maddux B, Grodsky G. 2002. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocrine Rev 23:599-622.
24. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo R. 2005. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: A new analysis. J Clin Endocr Metabol 90:493-500.
25. Fujioka K, Shibamoto T. 2004. Formation of genotoxic dicarbonyl compounds in dietary oils upon oxidation. Lipids 39:481 - 6.
26. Gladden L. 2001. Lactic acid: New roles in a new millennium. Proc Nad Acad Sci. USA 98:395-7.
27. Golubev A. 1996. The other side of metabolism. Biochemistry (Mosc) 61:2018-39.
28. Gulotta M, Deng H, Dyer R, Callender R. 2002. Toward an understanding of the role of dynamics on enzymatic catalysis in lactate dehydrogenase. Biochemistry 41:3353-63.
29. Hayden M, Tyagi S. 2003. Is type 2 diabetes mellitus a vascular disease (atheroscleropathy) with hyperglycemia a late manifestation? The role of NOS, NO, and redox stress. Cardiovasc Diabetol 2:2-11.
30. Havel P. 2002. Control of energy homeostasis and insulin action by adipocyte hormones: Leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 13:51-9.
31. Hipkiss A. 2000. Carnosine and protein carbonyl groups: A possible relationship. Biochemistry (Mosc) 65:771-8.
32. Ihara Y, Yamada Y, Toyokuni S, Miyawaki K, Ban N, Adachi T, Kuroe A, Iwakura T, Kubota A, et al. 2000. Antioxidant alphatocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Lett 473:24-6.
33. Ishii M, Shimizu S, Shiota K, Yamamoto S, Kiuchi Y, Yamamoto T. 2002. Stimulation of tetrahydrobiopterin synthesis induced by insulin: Possible involvement of phosphatidyl-inositol 3-kinase. Int J Biochem Cell Biol 33:65-73.
34. Jiang Q, Ames B. 2003. γ-tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J 17:816-22.
35. Katakam P, Ujhelyi M, Hoenig M, Miller A. 1998. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol 275:R788-92.
36. Kemppainen J, Tsuchida H, Stolen K, Karlsson H, Bjornholm M, Heinonen O, Nuutila P, Rook A, Knuuti J, Zierath J. 2003. Insulin signalling and resistance in patients with chronic heart failure. J Physiol (Lond) 550:305-15.
37. Kemppainen J, Aalto S, Fujimoto T, Kalliokoski K, Langsjo J, Oikonen V, Rinne J, Nuutila P, Knuuti J. 2005. High intensity exercise decreases global brain glucose uptake in human. J Physiology 568:323-32.
38. Kilhovd B, Giardino I, Torjesen P, Birkeland K, Berg T, Thornalley P, Brownlee M, Hanssen K. 2003. Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism 52:163-8.
39. Koch M, Rett K, Volk A, Maerker E, Haist K, Deninger M, Renn W, Haring H. 1999. Amino acid polymorphism Gly 972 Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 107:318-27.
40. Kondoh Y, Kawase M, Ohmori S. 1992. D-Lactate concentrations in blood, urine and sweat before and after exercise. Eur J Appl Physiol Occup Physiol 65:88-93.
41. Kumar S, McGinnis J, de Vellis J. 1980. Catecholamine regulation of lactate dehydrogenase in rat brain cell culture. J Biol Chem 255:2315-21.
42. Lapolla A, Flamoni R, Dalla Vedova A, Senesi A, Reitano R, Fedele D, Basso E, Seraglia R, Traldi P. 2003. Glyoxal and methylglyoxal levels in diabetic patients: Quantitative determination by a new GC/MS method. Clin Chem Lab Med 41:1166-73.
43. Lyles G. 1996. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: Biochemical, pharmacological and toxicological aspects. Int J Biochem Cell Biol 28:259-74.
44. MacDonald M, Chaplen F, Triplett C, Gong Q, Drought H. 2006. Stimulation of insulin release by glyceraldehyde may not be similar to glucose. Arch Biochem Biophys 447:118-26.
45. Maechler P. 2003. Novel regulation of insulin secretion: The role of mitochondria. Curr Opin Invest Drugs 4:1166-72.
46. Marchetti P, Lupi R, Federici M, Marcelli L, Masini M, Boggi U, Del Guerra S, Patane G, Piro S, Anello M, et al. 2002. Insulin secretory function is impaired in isolated human islets carrying the Gly(972) → Arg IRS-1 polymorphism. Diabetes 51:1419-24.
47. Marti R, Valera E, Segura R, Alegre J, Surinach J, Pascual C. 1997. Determination of D-lactate by enzymatic methods in biological fluids: Study of interferences. Clin Chem 43:1010-15.
48. McLellan A, Thornalley P, Benn J, Sonksen P. 1994. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci 87:21-9.
49. Min K, Kovall R, Hendrickson W. 2003. Crystal structure of human alpha-tocopherol transfer protein bound to its ligand: Implications for ataxia with vitamin E deficiency. Proc Natl Acad Sci USA 100:14713-8.
50. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek M, Beebe D, Oates P, Hammes H, et al. 2000. Normalizing mitochondrial Superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-90.
51. Nohara Y, Usui T, Kinoshita T, Watanabe M. 2002. Generation of superoxide anions during the reaction of guanidino compounds with methylglyoxal. Chem Pharm Bull 50:179-84.
52. Papadia F, Marinari G, Camerini G, Civalleri D, Scopinaro N, Adami G. 2003. Leptin and insulin action in severely obese women. Obes Surg 13:241-4.
53. Park Y, Koh Y, Takahashi M, Miyamoto Y, Suzuki K, Dohmae N, Takio K, Honke K, Taniguchi N. 2003. Identification of the binding site of methylglyoxal on glutathione peroxidase: Methylglyoxal inhibits glutathione peroxidase activity via binding to glutathione binding sites Arg 184 and 185. Free Radic Res 37:205-11.
54. Plewka A, Kaminski M, Plewka D. 1998. Ontogenesis of hepatocyte respiration processes in relation to rat liver cytochrome P450-dependent monooxygenase system. Mech Ageing Dev 105:197-207.
55. Rakugi H, Kamide K, Ogihara T. 2002. Vascular signaling pathways in the metabolic syndrome. Curr Hypertens Rep 4:105-11.
56. Reynolds R, Walker B. 2003. Human insulin resistance: The role of glucocorticoids. Diabetes Obesity and Metabol 5:5-12.
57. Roy S, Biswas S, Ray M, Ray S. 2003. Protective effect of creatine against inhibition by methylglyoxal of mitochondrial respiration of cardiac cells. Biochem J 372:6619.
58. Sakai T, Okano T, Makino H, Tsudzuki T. 1976. Activation of cyclic AMP phospho-diesterase by a new vitamin E derivative. Cyclic Nucleotide Res 2:163-70.
59. Scheuermann-Freestone M, Madsen P, Manners D, Blamire A, Buckingham R, Styles P, Radda, Neubauer S, Clarke K. 2003. Abnormal cardiac and skeletal muscle energy metabolism patients with type 2 diabetes. Circulation 107:3040-6.
60. Schock B, Van der Vliet A, Corbacho A, Leonard S, Finkelstein E, Valacchi G, Obermueller U, Cross C, Traber M. 2004. Enhanced inflammatory responses in α-tocopherol transfer protein null mice. Arch Biochem Biophys 423:162-9.
61. Schulze P, Gielen S, Schuler G, Hambrecht R. 2002. Chronic heart failure and skeletal muscle catabolism: Effects of exercise training. Int J Cardiol 85:141-9.
62. Seidler N, Yeargans G. 2002. Effects of thermal denaturation on protein glycation. Life Sei 70:1789-99.
63. Seidler N, Kowalewski G. 2003. Methylglyoxal-induced glycation affects protein topography. Arch Biochem Biophys 410:149-54.
64. Shaheen A, Hamdy M, Kheir-Eldin A, Lindstrom P, el-Fattah A. 1993. Effect of pretreatment with vitamin E or diazepam on brain metabolism of stressed rats. Bioch Pharmacol 46:194-7.
65. Stumvoll M, Fritsche A, Volk A, Stefan N, Madaus A, Maerker E, Tiegeler A, Koch M, Machicao F, Haring H. 2001. The Gly972Arg polymorphism in the insulin receptor substrate-1 gene contributes to the variation in insulin secretion in normal glucose-tolerant humans. Diabetes 50:882-5.
66. Szent-Gyorgyi A. 1968. Bioelectronics. NY, London: Academic Press.
67. Takayama K, Nakano M, Zinner K, Vidigal C, Duran N, Shimizu Y, Cilento G. 1976. Generation of electronic energy in the myoglobin-catalyzed oxidation of acetoacetate to methylglyoxal. Arch Biochem Biophys 176:663-70.
68. Tambunan J, Kan Chang P, Li H, Natori M. 1998. Molecular cloning of a cDNA encoding a silkworm protein that contains the conserved BH regions of Bcl-2 family proteins. Gene 212:287-93.
69. Thornalley P, Langborg A, Minhas H. 1999. Formation of glyoxal, methylglyoxal and 3deoxyglucosone in the glycation of proteins by glucose. Biochem J 344:109-16.
70. Thornalley P, Jahan I, Ng R. 2001. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem (Tokyo) 129:543-9.
71. Unger R. 2004. The hyperleptinemia of obesity-regulator of caloric surpluses. Cell 117:1456.
72. Vander Jagt D, Hunsaker L. 2003. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyxalase-I, betaine aldehyde dehydrogenase and 2 oxoaldehyde dehydrogenase. Chem Biol Interact 143/144:341-51.
73. Vieira E, Liu Y, Gyfle E. 2004. Involvement of alpha 1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell. Naunyn-Schmiedeberg's Arch Pharmacol 369:179-83.
74. Werner N, Nickenig G. 2004. From fat fighter to risk factor: the zigzag trek of leptin. Arterioscler Thromb Vase Biol 24: 7-9.
75. White M. 2003. Insulin signaling in health and disease. Science 302:1710-11.
76. Wu L, Juurlink B. 2002. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 39:809-14.
77. Xiao X, Grove K, Grayson B, Smith M. 2004. Inhibition of uncoupling protein expression during lactation: Role of leptin. Endocrinology 145:830-8.
78. Yu P, Wright S, Fan E, Lun Z, Gubisne-Harberle D. 2003. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta 1647:193-9.
79. Yu P, Wang M, Deng Y, Fan H, Shira-Bock L. 2002. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet. Diabetologia 45:1255-62.
80. Zhao A, Shinohara M, Huang D, Shimizu M, Eldar-Finkelman H, Krebs E, Beavo J, Bornfeldt K. 2000. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem 275:11348-54.